New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Nancy Kartiko, MD
Advertisement
Dr Kartiko is a third-year psychiatry resident at Creighton University.
Articles by Nancy Kartiko, MD
Advertisement
Latest Updated Articles
Benzodiazepine Discontinuation Associated With Increased Mortality in Patients on Stable, Long-Term BenzodiazepinesPublished: April 16th 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms
2
Can the Initial Antipsychotic Influence Years of Weight Gain?
3
Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD
4
Loneliness, Meet Solitude
5
